ORKA (Oruka Therapeutics) Pre-Tax Income : $ Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Oruka Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Oruka Therapeutics's pretax income for the six months ended in Dec. 2024 was $0.00 Mil. Oruka Therapeutics does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in Dec. 2024. Oruka Therapeutics's pretax margin was %.

Oruka Therapeutics Pre-Tax Income Historical Data

The historical data trend for Oruka Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oruka Therapeutics Pre-Tax Income Chart

Oruka Therapeutics Annual Data

Trend

Dec24

Pre-Tax Income

Oruka Therapeutics Semi-Annual Data
	Dec24
Pre-Tax Income	-

Competitive Comparison of Oruka Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Oruka Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oruka Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oruka Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Oruka Therapeutics's Pre-Tax Income falls into.

Save Embed

;

Save Embed

;

Oruka Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Oruka Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	0	+	0	+	0	+	0	+	0
	=	0.00

Oruka Therapeutics's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	0	+	0	+	0	+	0	+	0
	=	0.00

Oruka Therapeutics (NAS:ORKA) Pre-Tax Income Explanation

Oruka Therapeutics's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	0	/	0
	=	%

Oruka Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Oruka Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Oruka Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oruka Therapeutics Inc (NAS:ORKA) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

HQ1:Germany

Address

855 Oak Grove Avenue, Suite 100, Menlo Park, CA, USA, 94025

Website

https://www.orukatx.com

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.